|
1
|
Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA.
|
FASEB J
|
1996
|
1.38
|
|
2
|
Contraction of human airways by oxidative stress protection by N-acetylcysteine.
|
Free Radic Biol Med
|
1999
|
0.86
|
|
3
|
Inhibitory effects of N-acetylcysteine on superoxide anion generation in human polymorphonuclear leukocytes.
|
J Pharm Pharmacol
|
1997
|
0.83
|
|
4
|
Effect of aging on glutathione metabolism. Protection by antioxidants.
|
EXS
|
1992
|
0.78
|
|
5
|
Role of L-arginine in ibuprofen-induced oxidative stress and neutrophil infiltration in gastric mucosa.
|
Free Radic Res
|
2004
|
0.77
|
|
6
|
Action of metadoxine on isolated human and rat alcohol and aldehyde dehydrogenases. Effect on enzymes in chronic ethanol-fed rats.
|
Methods Find Exp Clin Pharmacol
|
1991
|
0.76
|
|
7
|
Effect of N-acetylcysteine on the oxidative burst induced by phagocytosis of bacteria in human leukocytes.
|
Methods Find Exp Clin Pharmacol
|
1998
|
0.75
|
|
8
|
Administration of L-arginine reduces the delay of the healing process caused by ibuprofen. Implication of COX and growth factors expression.
|
Histol Histopathol
|
2005
|
0.75
|
|
9
|
Pharmacokinetic approach of plafibride in rat.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
10
|
[Serum levels and urinary and fecal excretion of ethamicylin HCI (solucylin). Oral and intravenous administration (author's transl)].
|
Arch Farmacol Toxicol
|
1980
|
0.75
|
|
11
|
Clinical trials of plafibride in geriatric patients.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
12
|
Toxicological studies of plafibride. Part 1: Acute toxicity and its determination after several administrations of plafibride.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
13
|
Influence of plafibride, an antiplatelet and hypolipemic agent, on prostacyclin and thromboxane synthesis, 3',5'-cyclic AMP phosphodiesterase activity and serum clearance of a lipid emulsion.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
14
|
[Pharmacological aspects of tienilic acid].
|
Arch Farmacol Toxicol
|
1981
|
0.75
|
|
15
|
Ocular pharmacokinetics of thiamphenicol in rabbits.
|
Arzneimittelforschung
|
1992
|
0.75
|
|
16
|
Pharmacological activities and side effects of plafibride.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
17
|
[Toxicological aspects of ITA 104].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
18
|
[Pharmacology and collateral effects of ITA 104].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
19
|
Activity of plafibride on erythrocyte deformability.
|
Arzneimittelforschung
|
1983
|
0.75
|
|
20
|
Hypolipemic activity of plafibride.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
21
|
Toxicological studies of plafibride. Part 3: Study of teratogenic activity in rats and rabbits.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
22
|
Bioavailability of plafibride in healthy volunteers.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
23
|
Microhaemorheological properties of binifibrate. Part II: Preliminary open studies in patients with peripheral arteriopathies.
|
Arzneimittelforschung
|
1983
|
0.75
|
|
24
|
Absorption of sodium diclofenac after ocular administration in rabbit.
|
Arzneimittelforschung
|
1998
|
0.75
|
|
25
|
Endothelial damage induced by polyethylene catheter in rat.
|
Methods Find Exp Clin Pharmacol
|
1982
|
0.75
|
|
26
|
Pharmacokinetics of thymoxamine in rabbits after ophthalmic and intravenous administration.
|
Eur J Drug Metab Pharmacokinet
|
1995
|
0.75
|
|
27
|
Toxicological studies of plafibride. Part 2: Subacute and subchronic toxicity in rats and chronic toxicity in dogs.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
28
|
Plafibride tolerance trial at increasing doses in healthy volunteers.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
29
|
Toxicological studies of plafibride. Part 4: Interaction of plafibride with other drugs.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
30
|
[Pharmacology of ITA 226 producing laxative activity].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
31
|
Synthesis and pharmacological evaluation of N'-morpholinomethylurea derivatives with platelet antiaggregant activity.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
32
|
Diuretic effect of ITA 529.
|
Methods Find Exp Clin Pharmacol
|
1984
|
0.75
|
|
33
|
[Data on metabolism of (4-chlorophenoxy)-isobutyric acid derivatives in various species of animal].
|
Boll Chim Farm
|
1969
|
0.75
|
|
34
|
Pseudomonas aeruginosa proteases: purification procedures for an enzymatic standard.
|
New Microbiol
|
1996
|
0.75
|
|
35
|
Anti-ulcer activity and other pharmacological properties of lozilurea.
|
Arzneimittelforschung
|
1983
|
0.75
|
|
36
|
[Unpublished pharmacological aspects of meclofenoxate (centrophenoxine)].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
37
|
Microhaemorheological properties of binifibrate. Part I: Experimental studies.
|
Arzneimittelforschung
|
1983
|
0.75
|
|
38
|
[Pharmacology of a new derivative with anti-inflammatory activity: ITA 194].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
39
|
Plafibride tolerance trial in healthy volunteers.
|
Arzneimittelforschung
|
1981
|
0.75
|
|
40
|
[ITA 104, a product of antiplatelet aggregation activity].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
41
|
[Pharmacology of ITA 213, a producer of anorexic activity].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
42
|
[Hypolipemic activity of ITA 104].
|
Arch Farmacol Toxicol
|
1978
|
0.75
|
|
43
|
Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
|
Arzneimittelforschung
|
1981
|
0.75
|